Enoxaparin LMWH

Clexane - Lovenox      

pdf
pathology Demonstrated benefit and harm k      
acute coronary syndrome

versus

No demonstrated result for efficacy

1 trialmeta-analysis
acute coronary syndrome

versus LMWH

No demonstrated result for efficacy

1 trialmeta-analysis
acute coronary syndrome

versus UFH

No demonstrated result for efficacy

enoxaparin inferior to UFH (on top of aspirin) in terms of minor bleeding in ESSENCE, 1997

enoxaparin inferior to UFH (on top of aspirin) in terms of minor bleeding in TIMI 11 B (short term), 1998

enoxaparin inferior to UFH (on top of aspirin) in terms of major bleeding in SYNERGY, 2005

enoxaparin inferior to UFH (on top of aspirin) in terms of minor bleeding in INTERACT, 2006

enoxaparin inferior to UFH (on top of aspirin) in terms of major bleeding in TIMI 11 B (long term), 1998

enoxaparin inferior to UFH (on top of aspirin) in terms of minor bleeding in TIMI 11 B (long term), 1998

5 trialsmeta-analysis
acute myocardial infarction

versus placebo or control

No demonstrated result for efficacy

1 trialmeta-analysis
acute myocardial infarction

versus heparin

No demonstrated result for efficacy

5 trialsmeta-analysis
heart failure

versus UFH

No demonstrated result for efficacy

1 trialmeta-analysis
percutaneous coronary intervention

versus heparin

No demonstrated result for efficacy

9 trialsmeta-analysis
pulmonary embolism

versus unfractioned heparin

No demonstrated result for efficacy

2 trialsmeta-analysis
superficial thrombophlebitis

versus placebo or control

No demonstrated result for efficacy

2 trialsmeta-analysis
thrombosis prevention

versus placebo or control

No demonstrated result for efficacy

enoxaparin inferior to no treatment in terms of total bleeding in Ho [43]

7 trialsmeta-analysis
thrombosis prevention

versus placebo or no treatment

No demonstrated result for efficacy

5 trialsmeta-analysis
thrombosis prevention

versus

No demonstrated result for efficacy

13 trialsmeta-analysis
thrombosis prevention

versus Dextran

No demonstrated result for efficacy

1 trialmeta-analysis
thrombosis prevention

versus UFH

No demonstrated result for efficacy

3 trialsmeta-analysis
thrombosis prevention

versus Unfractionated heparin

No demonstrated result for efficacy

2 trialsmeta-analysis
venous thrombosis

versus anticoagulant

No demonstrated result for efficacy

3 trialsmeta-analysis
venous thrombosis

versus oral anticoagulant

No demonstrated result for efficacy

Enoxaparin inferior to coumarin in terms of VTE during active anticoagulant treatment in González-Fajardo, 2008

6 trialsmeta-analysis
venous thrombosis

versus

No demonstrated result for efficacy

1 trialmeta-analysis
venous thrombosis

versus twice daily LMWH

No demonstrated result for efficacy

1 trialmeta-analysis
venous thrombosis

versus UFH

No demonstrated result for efficacy

1 trialmeta-analysis